Mon, March 11, 2024
Fri, March 8, 2024
Thu, March 7, 2024

Umer Raffat Downgraded (AMLX) to Hold on, Mar 8th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. fat-downgraded-amlx-to-hold-on-mar-8th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Umer Raffat of Evercore ISI Group, Downgraded "Amylyx Pharmaceuticals, Inc." (AMLX) to Hold on, Mar 8th, 2024.

Umer has made no other calls on AMLX in the last 4 months.



There are 4 other peers that have a rating on AMLX. Out of the 4 peers that are also analyzing AMLX, 0 agree with Umer's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Umer


  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $37 on, Wednesday, January 3rd, 2024
  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $36 on, Tuesday, December 12th, 2023
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $42 on, Friday, November 10th, 2023
  • Chris Shibutani of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 10th, 2023

Publication Contributing Sources